All In Biotech

Drug Trial Radar · NCT02547818

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

A Phase III Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Last checked: Nov 20, 2026Latest source record: Nov 10, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 620 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

620

Actual

Start

Sep 15, 2015

Primary completion

Nov 13, 2020

Study completion Nov 18, 2020

Sponsor

Lead sponsor
AZTherapies, Inc.Industry
Sponsor type
Industry
Collaborators
PharmaConsulting Group; KCAS Bio; APCER Life Sciences
First posted
Sep 11, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 55 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a global Phase III, randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The protocol is designed to determine whether ALZT-OP1 combination treatment (ALZT-OP1a + ALZT-OP1b) will slow down, arrests, or reverse cognitive and functional decline, in subjects with evidence of early stage Alzheimer's disease (AD).

Conditions

  • Alzheimer's Disease

Interventions

  • ALZT-OP1aDrug

    1\) Mast cell stabilizer, 2) Neuroinflammatory microglial modulator, 3) A-beta oligomerization inhibitor, and 4) anti-inflammatory

  • ALZT-OP1bDrug

    Anti-inflammatory

  • Placebo ALZT-OP1aOther

    Non-active capsules

  • Placebo ALZT-OP1bOther

    Non-active tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Dementia Rating-Sum of Boxes (CDR-SB)Time frame: Baseline and Week 72

Locations

121 sites in 7 countries. Site status is shown where the registry gives one.

  • Cognitive Clinical Trials

    Gilbert, Arizona

  • Xenoscience

    Phoenix, Arizona

  • Cognitive Clinical Trials

    Scottsdale, Arizona

  • Territory Neurology & Research Institute

    Tucson, Arizona

  • Alliance Research Center

    Laguna Hills, California

  • Renew Behavioral Health

    Long Beach, California

  • Excell Research, Inc.

    Oceanside, California

  • University of California Irvine School of Medicine

    Orange, California

  • Asclepes Research Center

    Panorama City, California

  • Artemis Clinical Research

    Riverside, California

  • CITrials

    Riverside, California

  • Northern California Research

    Sacramento, California

  • Syrentys Clinical Research

    Santa Ana, California

  • Mile High Research Center

    Denver, Colorado

  • TOPAZ Clinical Research

    Apopka, Florida

  • Parkinson's Disease & Movement Disorders Center of Boca Raton

    Boca Raton, Florida

  • Bradenton Research Center

    Bradenton, Florida

  • Finlay Medical Research Group

    Greenacres City, Florida

  • Galiz Clinical Research

    Hialeah, Florida

  • The Neurology Research Group

    Miami, Florida

  • Premier Clinical Research Institute

    Miami, Florida

  • Finlay Medical Research Group

    Miami, Florida

  • Next Phase Research Alliance - Cano Health

    Miami, Florida

  • IMIC, Inc.

    Miami, Florida

  • Next Phase Research Alliance - MetroMed

    Miami, Florida

  • Next Phase Research Alliance

    Miami, Florida

  • Panax

    Miami Lakes, Florida

  • CNS Healthcare

    Orlando, Florida

  • Pines Care Research Center

    Pembroke Pines, Florida

  • Neurostudies, Inc.

    Port Charlotte, Florida

  • Progressive Medical Research

    Port Orange, Florida

  • Axiom Clinical Research

    Tampa, Florida

  • Stedman Clinical Trials

    Tampa, Florida

  • Columbus Research & Wellness Institute

    Columbus, Georgia

  • Behavioral Health Care Associates

    Schaumburg, Illinois

  • Eastern Maine Medical Center

    Bangor, Maine

  • Coastal Health Care

    Freeport, Maine

  • Samuel and Alexia Bratton Memory Clinic

    Easton, Maryland

  • ActivMed Practices & Research, Inc.

    Methuen, Massachusetts

  • The Alzheimer's Disease Center

    Quincy, Massachusetts

Showing 40 of 121 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.